Alison Stopeck
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer (NCT06220214) | Alison Stopeck | 2024-03-06 |
| Sulindac and Breast Density in Women at Risk of Developing Breast Cancer (NCT04542135) | Alison Stopeck | 2020-11-20 |
| Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer (NCT04088032) | Alison Stopeck | 2019-10-01 |
Track Alison Stopeck automatically
Every clearance here is in the API, with alerts when new ones post.